5AM Ventures IV, L.P. → IDEAYA Biosciences, Inc. IDYA

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 25/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (12.0 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 12.03

9,079,434 shares short · -1.1% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $63.77M

Point72 Asset Mgmt

Other 13D/G Filings on IDEAYA Biosciences, Inc.

Filed	Form	Filer	Stake	Shares
2021-08-11	SC	5AM Ventures IV, L.P.	—	—	view →
2020-11-16	SC	5AM Ventures IV, L.P.	—	—	view →

Other Filings by 5AM Ventures IV, L.P.

Filed	Form	Issuer	Stake	Shares
2022-09-16	SC	Pear Therapeutics, Inc.	—	—	view →
2021-08-11	SC	IDEAYA Biosciences, Inc. IDYA	—	—	view →
2021-02-16	SC	Aprea Therapeutics, Inc. APRE	—	—	view →
2020-11-19	SC	Aprea Therapeutics, Inc. APRE	—	—	view →
2020-11-16	SC	IDEAYA Biosciences, Inc. IDYA	—	—	view →
2020-10-07	SC	Aprea Therapeutics, Inc. APRE	—	—	view →
2020-06-16	SC	Aprea Therapeutics, Inc. APRE	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →